Speaker illustration

Professor Dobromir Dobrev

University Hospital of Essen (Ruhr), Essen (Germany)

Member of:

European Society of Cardiology
European Heart Rythm Association
Heart Failure Association

Dr. Dobrev is Full Professor and Director of Institute of Pharmacology, Faculty of Medicine, University Duisburg-Essen, Essen, Germany. He also serves as Adjunct Full Professor of Medicine at Montreal Heart Institute, University of Montreal, Canada and Baylor College of Medicine, Houston, USA. His main research interest is the molecular basis of disease-related cardiac remodeling and arrhythmias and identification and validation of novel antiarrhythmic targets. Dr. Dobrev is recognized nationally and internationally as an expert in cardiovascular research.

Regulatory aspects

Event: All About Clinical Trials

Topic: Training and Education

Session type: Symposium

Thumbnail

Combined antithrombotic therapy in patients with obstructive coronary artery disease

Event: EuroCVP 2023 – The annual meeting on advances in cardiovascular pharmacotherapy

Topic: Cardiovascular Pharmacotherapy

Session type: Teaching Course

Thumbnail

Antithrombotic therapy in special populations

Event: EuroCVP 2023 – The annual meeting on advances in cardiovascular pharmacotherapy

Topic: Cardiovascular Pharmacotherapy

Session type: Teaching Course

Thumbnail

Anticoagulation for stroke prevention in older patients with atrial fibrillation

Event: Pharmacotherapy in Older People (POP) 2023

Topic: Pharmacology and Pharmacotherapy

Session type: Symposium

Thumbnail

Antiarrhythmics: challenges to prescription of antiarrhythmics in older patients

Event: Pharmacotherapy in Older People (POP) 2023

Topic: Pharmacology and Pharmacotherapy

Session type: Symposium

Thumbnail

Issues in clinical trials: Devices

Event: All About Clinical Trials (AACT)

Topic: Research Methodology

Session type: Teaching Course

Thumbnail

Insight into atrial physiology and pathology

Event: ESC Congress 2019

Topic: Arrhythmias

Session type: Moderated Posters

Thumbnail

Critical appraisal of antiarrhythmic drug therapy - The science behind trial-and-error

Event: EHRA 2019

Topic: Arrhythmias

Session type: New ESC Guidelines

Thumbnail

Molecular basis for arrhythmias and beyond

Event: Frontiers in CardioVascular Biology 2018

Topic: Cardiac Biology and Physiology

Session type: Featured Symposium

Thumbnail

Atrial cardiomyopathy and fibrillation

Event: EHRA 2018

Topic: Atrial Fibrillation - Pathophysiology and Mechanisms

Session type: Symposium

Thumbnail